Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066719
  • May 2021
  • Pharmaceuticals
  • 115 Pages
The Travel Vaccines Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Abbott Laboratories, Baxter International, Inc., Dynavax Technologies Corporation, Emergent BioSolutions, F. Hoffman-La Roche Ltd., GSK group, Janssen Global Services, LLC, Pfizer Inc., Shenzhen Kangtay Biological Products Co., Ltd., Zydus Cadila
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Travel Vaccines market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Travel Vaccines market is expected to attain Pre COVID-19 levels by mid-2022.

Travel Vaccines Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Travel Vaccines market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Travel Vaccines Market Competitive and Premeditated Analysis
In the Travel Vaccines report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Travel Vaccines research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Travel Vaccines Market:
The Travel Vaccines market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abbott Laboratories, Baxter International, Inc., Dynavax Technologies Corporation, Emergent BioSolutions, F. Hoffman-La Roche Ltd., GSK group, Janssen Global Services, LLC, Pfizer Inc., Shenzhen Kangtay Biological Products Co., Ltd., Zydus Cadila

The Travel Vaccines market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Travel Vaccines Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Travel Vaccines market:
By Type
Mono vaccines
Combination Vaccines

Regional Analysis of the Travel Vaccines market:
The Travel Vaccines market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Travel Vaccines report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Travel Vaccines market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Travel Vaccines market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Travel Vaccines market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Travel Vaccines market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Travel Vaccines market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Travel Vaccines market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Travel Vaccines market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Travel Vaccines market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Abbott Laboratories
  • Baxter International, Inc.
  • Dynavax Technologies Corporation
  • Emergent BioSolutions
  • F. Hoffman-La Roche Ltd.
  • GSK group
  • Janssen Global Services, LLC
  • Pfizer Inc.
  • Shenzhen Kangtay Biological Products Co., Ltd.
  • Zydus Cadila
  • Mono vaccines
  • Combination Vaccines
  • Mono vaccines
  • Combination Vaccines

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Travel Vaccines Market Snapshot
          2.1.1. Global Travel Vaccines Market By Type,2019
               2.1.1.1.Mono vaccines
               2.1.1.2.Combination Vaccines
          2.1.2. Global Travel Vaccines Market By Type,2019
               2.1.2.1.Mono vaccines
               2.1.2.2.Combination Vaccines
          2.1.3. Global Travel Vaccines Market By End-use,2019
          2.1.4. Global Travel Vaccines Market By Geography,2019

3. Global Travel Vaccines Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Travel Vaccines Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Travel Vaccines Market Size (US$), By Type, 2018 – 2028

5. Global Travel Vaccines Market Size (US$), By Type, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Type, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Type, 2020
     5.2. Global Travel Vaccines Market Size (US$), By Type, 2018 – 2028

6. Global Travel Vaccines Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Travel Vaccines Market Size (US$), By End-use, 2018 – 2028

7. Global Travel Vaccines Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Travel Vaccines Market Analysis, 2018 – 2028 
          7.2.1. North America Travel Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Travel Vaccines Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Travel Vaccines Market Size (US$), By Type, 2018 – 2028
          7.2.4. North America Travel Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Travel Vaccines Market Analysis, 2018 – 2028 
          7.3.1.  Europe Travel Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Travel Vaccines Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Travel Vaccines Market Size (US$), By Type, 2018 – 2028
          7.3.4. Europe Travel Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Travel Vaccines Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Travel Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Travel Vaccines Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Travel Vaccines Market Size (US$), By Type, 2018 – 2028
          7.4.4. Asia Pacific Travel Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Travel Vaccines Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Travel Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Travel Vaccines Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Travel Vaccines Market Size (US$), By Type, 2018 – 2028
          7.5.4. Latin America Travel Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Travel Vaccines Market Analysis, 2018 – 2028 
          7.6.1.  MEA Travel Vaccines Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Travel Vaccines Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Travel Vaccines Market Size (US$), By Type, 2018 – 2028
          7.6.4. MEA Travel Vaccines Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Travel Vaccines Providers
        8.4.1 Abbott Laboratories
                8.4.1.1 Business Description
                8.4.1.2 Abbott Laboratories Geographic Operations
                8.4.1.3 Abbott Laboratories Financial Information
                8.4.1.4 Abbott Laboratories Product Positions/Portfolio
                8.4.1.5 Abbott Laboratories Key Developments
        8.4.2 Baxter International, Inc.
                8.4.2.1 Business Description
                8.4.2.2 Baxter International, Inc. Geographic Operations
                8.4.2.3 Baxter International, Inc. Financial Information
                8.4.2.4 Baxter International, Inc. Product Positions/Portfolio
                8.4.2.5 Baxter International, Inc. Key Developments
        8.4.3 Dynavax Technologies Corporation
                8.4.3.1 Business Description
                8.4.3.2 Dynavax Technologies Corporation Geographic Operations
                8.4.3.3 Dynavax Technologies Corporation Financial Information
                8.4.3.4 Dynavax Technologies Corporation Product Positions/Portfolio
                8.4.3.5 Dynavax Technologies Corporation Key Developments
        8.4.4 Emergent BioSolutions
                8.4.4.1 Business Description
                8.4.4.2 Emergent BioSolutions Geographic Operations
                8.4.4.3 Emergent BioSolutions Financial Information
                8.4.4.4 Emergent BioSolutions Product Positions/Portfolio
                8.4.4.5 Emergent BioSolutions Key Developments
        8.4.5 F. Hoffman-La Roche Ltd.
                8.4.5.1 Business Description
                8.4.5.2 F. Hoffman-La Roche Ltd. Geographic Operations
                8.4.5.3 F. Hoffman-La Roche Ltd. Financial Information
                8.4.5.4 F. Hoffman-La Roche Ltd. Product Positions/Portfolio
                8.4.5.5 F. Hoffman-La Roche Ltd. Key Developments
        8.4.6 GSK group
                8.4.6.1 Business Description
                8.4.6.2 GSK group Geographic Operations
                8.4.6.3 GSK group Financial Information
                8.4.6.4 GSK group Product Positions/Portfolio
                8.4.6.5 GSK group Key Developments
        8.4.7 Janssen Global Services, LLC
                8.4.7.1 Business Description
                8.4.7.2 Janssen Global Services, LLC Geographic Operations
                8.4.7.3 Janssen Global Services, LLC Financial Information
                8.4.7.4 Janssen Global Services, LLC Product Positions/Portfolio
                8.4.7.5 Janssen Global Services, LLC Key Developments
        8.4.8 Pfizer Inc.
                8.4.8.1 Business Description
                8.4.8.2 Pfizer Inc. Geographic Operations
                8.4.8.3 Pfizer Inc. Financial Information
                8.4.8.4 Pfizer Inc. Product Positions/Portfolio
                8.4.8.5 Pfizer Inc. Key Developments
        8.4.9 Shenzhen Kangtay Biological Products Co., Ltd.
                8.4.9.1 Business Description
                8.4.9.2 Shenzhen Kangtay Biological Products Co., Ltd. Geographic Operations
                8.4.9.3 Shenzhen Kangtay Biological Products Co., Ltd. Financial Information
                8.4.9.4 Shenzhen Kangtay Biological Products Co., Ltd. Product Positions/Portfolio
                8.4.9.5 Shenzhen Kangtay Biological Products Co., Ltd. Key Developments
        8.4.10 Zydus Cadila
                8.4.10.1 Business Description
                8.4.10.2 Zydus Cadila Geographic Operations
                8.4.10.3 Zydus Cadila Financial Information
                8.4.10.4 Zydus Cadila Product Positions/Portfolio
                8.4.10.5 Zydus Cadila Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Travel Vaccines Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Travel Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Travel Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Travel Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Travel Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Travel Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Travel Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Travel Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Travel Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Travel Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Travel Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Travel Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Travel Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Travel Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Travel Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Travel Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Travel Vaccines: Market Segmentation 
FIG. 2 Global Travel Vaccines Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Travel Vaccines Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Travel Vaccines Market, By Type, 2019 (US$ Mn) 
FIG. 6 Global Travel Vaccines Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Travel Vaccines Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Travel Vaccines Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Travel Vaccines Providers, 2019
FIG. 11 Global Travel Vaccines Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Travel Vaccines Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 13 Global Travel Vaccines Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Travel Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Travel Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Travel Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Travel Vaccines Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Travel Vaccines Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Travel Vaccines market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Travel Vaccines Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Travel Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  North America Travel Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  North America Travel Vaccines Market Value, By Country, 2018 – 2028
TABLE  Europe Travel Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Europe Travel Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Europe Travel Vaccines Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Travel Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Travel Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Travel Vaccines Market Value, By Country, 2018 – 2028
TABLE  Latin America Travel Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Travel Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Travel Vaccines Market Value, By Country, 2018 – 2028
TABLE  MEA Travel Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  MEA Travel Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  MEA Travel Vaccines Market Value, By Country, 2018 – 2028
TABLE  Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Baxter International, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Dynavax Technologies Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Emergent BioSolutions: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffman-La Roche Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GSK group: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Janssen Global Services, LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Shenzhen Kangtay Biological Products Co., Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Zydus Cadila: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Travel Vaccines Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Travel Vaccines Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Travel Vaccines Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Travel Vaccines Market, By Geography, 2019 (US$ Mn)
FIG.  Global Travel Vaccines Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Travel Vaccines Providers, 2016
FIG.  Global Travel Vaccines Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Combination Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Travel Vaccines Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Combination Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Travel Vaccines Market Value, 2018 – 2028, (US$ Mn)